editor
pleas
read
chen
et
al
commentari
present
practic
method
reduc
spread
coronaviru
diseas
dermatolog
set
health
care
team
around
world
work
dilig
limit
spread
despit
unpreced
challeng
letter
provid
addit
strategi
potenti
framework
maintain
success
patient
care
limit
risk
faculti
resid
staff
commun
outbreak
first
goal
pandem
limit
spread
viru
prevent
infect
entir
specialti
group
depart
consid
adopt
teambas
practic
model
limit
crosscontamin
team
consist
ratio
provid
base
individu
institut
workforc
exampl
team
depart
consist
attend
physician
resid
physician
nurs
medic
assist
support
staff
member
individu
clinic
team
conduct
inperson
visit
day
allow
inperson
contact
member
outsid
design
team
event
team
member
expos
test
posit
individu
within
team
requir
selfquarantin
day
andor
subsequ
test
use
approach
crosscontamin
limit
thu
depart
continu
oper
deliv
inperson
care
despit
exposur
continu
effect
patient
care
limit
exposur
implement
code
triag
system
allow
us
priorit
provid
appropri
care
patient
fig
tabl
key
step
implement
model
earli
possibl
combin
teledermatolog
practic
alreadi
suggest
depict
diagram
patient
high
acuiti
individu
concern
lesion
potenti
lifethreaten
erupt
prioriti
inperson
visit
simultan
continu
care
exist
patient
achiev
teledermatolog
system
patient
continu
longterm
manag
decreas
risk
exposur
inpati
visit
unavoid
chen
et
al
detail
addit
precaut
implement
reduc
spread
recommend
includ
allow
accompani
person
per
patient
mask
usag
temperatur
read
peopl
enter
inpati
outpati
build
use
person
protect
equip
ppe
team
member
work
patient
suspect
confirm
agre
recommend
although
ppe
short
suppli
restrict
success
implement
altern
steril
ppe
equip
help
mitig
limit
outbreak
challeng
medic
commun
unit
togeth
halt
spread
outbreak
continu
evolv
hope
develop
implement
procedur
limit
spread
ensur
optim
patient
care
achiev
dermatolog
thank
chen
et
al
contribut
improv
patient
care
safeti
unpreced
time
scientif
incent
transact
financi
otherwis
relev
manuscript
dr
curiellewandrowski
serv
advisori
board
member
andor
investig
andor
receiv
research
fund
amgen
bristolmy
squibb
helsinn
novarti
incent
transact
financi
otherwis
relev
manuscript
ms
price
dr
thied
conflict
interest
declar
